Coherus Biosciences | CHRS - Loan Capital

Stock Price
1.99
Daily Change
0.24 13.71%
Monthly
16.37%
Yearly
95.10%
Q2 Forecast
1.71

Coherus Biosciences reported $51.08M in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
AbbVie USD 58.94B 4.03B Dec/2025
Acadia Pharmaceuticals USD 0 0 Mar/2025
Akebia Therapeutics USD 36.39M 11.85M Mar/2026
ALKERMES USD 1.48B 1.2B Mar/2026
Alnylam Pharmaceuticals USD 2.48B 931K Mar/2026
Amgen USD 51.89B 1.88B Mar/2026
Baxter International USD 8.62B 852M Mar/2026
Biogen USD 6.29B 1.7M Mar/2026
BioMarin Pharmaceutical USD 1.43B 833.11M Mar/2026
Bristol-Myers Squibb USD 42.15B 698M Mar/2026
Coherus Biosciences USD 51.08M 496K Dec/2025
Eli Lilly USD 39.37B 1.5B Mar/2026
Fujifilm JPY 642.24B 70.37B Dec/2025
Gilead Sciences USD 20.86B 1.27B Mar/2026
Ironwood Pharmaceuticals USD 583.99M 14.83M Dec/2024
Merck USD 46.67B 77M Mar/2026
Myriad Genetics USD 120.3M 400K Mar/2026
Pacira USD 367.66M 4.53M Mar/2026
Perrigo USD 3.62B 17.5M Mar/2026
Pfizer USD 60.57B 1.08B Mar/2026
PTC Therapeutics USD 286.94M 1.74B Mar/2026
Regeneron Pharmaceuticals USD 1.99B 719.7M Mar/2026
Sarepta Therapeutics USD 838.16M 9.19M Mar/2026
Teva Pharmaceutical Industries USD 14.02B 971M Mar/2026
Vertex Pharmaceuticals USD 106.7M 4.7M Dec/2025
Xencor USD 82.12M 5.64M Mar/2026
Zoetis USD 9.04B 3M Mar/2026